多焦点人工晶状体白内障术前OCT筛查的成本效果分析
该成本效果分析评估了67岁男性患者首次白内障术前附加筛查OCT以检出黄斑病变(如视网膜前膜、年龄相关性黄斑变性、玻璃体黄斑牵拉、囊样黄斑水肿)的成本效果。结果显示,附加术前OCT虽增加费用,但可提高黄斑病变检出并改善质量调整生命年,在美国第三方付费者和社会视角下具有成本效果。
要点
- 约20.5%白内障手术患者可能存在黄斑病变,其中11%可能在初诊临床检查中未被发现。
- 在基础分析中,附加术前OCT在美国第三方付费者和社会视角下均具有成本效果。
核心结论
- 在考虑多焦点人工晶状体的白内障术前评估中,附加筛查OCT可提高黄斑病变检出并改善质量调整生命年,在美国第三方付费者和社会视角下具有成本效果。
研究设计与样本
- 成本效果分析,对象为一名67岁、视力20/60、拟行首次白内障手术的男性患者。
- 比较术前白内障检查联合或不联合筛查OCT,评估视网膜前膜、年龄相关性黄斑变性、玻璃体黄斑牵拉和囊样黄斑水肿等玻璃体视网膜疾病。
主要发现
- 约20.5%接受白内障手术的患者可能存在黄斑病变,其中11%可能在初诊临床检查中未被发现。
- 在基础分析中,附加术前OCT在美国第三方付费者和社会视角下均具有成本效果。
关键数值与推荐
- OCT的Medicare可报销成本为41.81美元。
- 所有成本和收益均按通货膨胀调整至2019年美元,并在16年时间范围内按每年3%贴现。
临床怎么用
- 对于考虑多焦点人工晶状体的白内障术前患者,可附加筛查OCT以检出初诊检查可能遗漏的黄斑病变。
- 若术前OCT检出黄斑病变,则假设患者改植入单焦点人工晶状体并转诊视网膜专科进行评估和管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the cost effectiveness of an adjunctive screening OCT during the preoperative evaluation of a patient considering cataract surgery with a multifocal intraocular lens (IOL) implantation. DESIGN: Cost-effectiveness analysis. PARTICIPANTS: A 67-year-old man with 20/60 vision undergoing evaluation for first-eye cataract surgery. METHODS: The cost-effectiveness analysis of the reference patient undergoing a preoperative cataract examination with and without a screening OCT was performed, evaluating for vitreoretinal diseases including an epiretinal membrane, age-related macular degeneration, vitreomacular traction, and cystoid macular edema. It was assumed that patients with macular pathologies detected before surgery would receive a monofocal IOL and be referred to a retina specialist for evaluation and management. The Medicare reimbursable cost of an OCT was $41.81. All costs and benefits were adjusted for inflation to 2019 United States dollars and discounted 3% per annum over a 16-year time horizon. Probability sensitivity analyses and 1-way deterministic sensitivity analyses were performed to assess for uncertainty. MAIN OUTCOME MEASURES: Incremental cost-effectiveness ratio and incremental cost-utility ratio (ICUR) measured in quality-adjusted life years (QALYs). RESULTS: Approximately 20.5% of patients undergoing cataract surgery may have macular pathologies, of which 11% may not be detected on the initial clinical examination. In the base case, an adjunctive preoperative OCT was cost effective from a third-party payer and societal perspective in the United States. In the probability sensitivity analyses, the ICURs were within the societal willingness-to-pay threshold of $50 000/QALY in approximately 64.4% of the clinical scenarios. CONCLUSIONS: A preoperative screening OCT during the evaluation of a patient considering a multifocal IOL added to the costs of the cataract surgery, but the OCT increased the detection of macular pathologies and improved the QALYs over time. An adjunctive screening OCT can be cost effective from a third-party payer and societal perspective.
引用
- Leung EH, Gibbons A, Koch DD, et al. Cost-Effectiveness of Preoperative OCT in Cataract Evaluation for Multifocal Intraocular Lens. Ophthalmology. 2020. PMID: 32173111. doi:10.1016/j.ophtha.2020.01.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。